GATA-binding protein 1 is a novel transcription regulator of peroxiredoxin 5 in human breast cancer cells

International Journal of Oncology

Volumn 40, Issue 3, 2012, Pages 655-664

  Seo, Min Ji ^a   Liu, Xiyuan ^a   Chang, Minsun ^a   Park, Jong Hoon ^a  

^a Sookmyung Women's University   (South Korea)

Author keywords

Apoptosis; Breast cancer; GATA1; Peroxiredoxin 5; Transcription factor

Indexed keywords

DOXORUBICIN; LUCIFERASE; PEROXIREDOXIN 5; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR GATA 1;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVITY; GENE CONTROL; GENE EXPRESSION; GENE SEQUENCE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; REPORTER GENE; TRANSCRIPTION REGULATION;

APOPTOSIS; BASE SEQUENCE; BINDING SITES; BREAST NEOPLASMS; CELL LINE, TUMOR; DNA-BINDING PROTEINS; FEMALE; GATA1 TRANSCRIPTION FACTOR; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; GENES, REPORTER; HUMANS; MOLECULAR SEQUENCE DATA; OXIDATIVE STRESS; PEROXIREDOXINS; PROMOTER REGIONS, GENETIC; TRANSCRIPTION, GENETIC;

EID: 84863115573     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2011.1236     Document Type: Article

References (49)

1. Beral V: Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 362: 419-427, 2003.
2. Seo MS, Kang SW, Kim K, Baines IC, Lee TH and Rhee SG: Identification of a new type of mammalian peroxiredoxin that forms an intramolecular disulfide as a reaction intermediate. J Biol Chem 275: 20346-20354, 2000. (Pubitemid 30457609)
3. Chang XZ, Li DQ, Hou YF, et al: Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer. Breast Cancer Res Treat 9: R76, 2007.
4. Clarke R, Liu MC, Bouker KB, et al: Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling. Oncogene 22: 7316-7339, 2003. (Pubitemid 37492898)
5. Egler RA, Fernandes E, Rothermund K, et al: Regulation of reactive oxygen species, DNA damage, and c-Myc function by peroxiredoxin 1. Oncogene 24: 8038-8050, 2005. (Pubitemid 41746747)
6. Neumann CA, Krause DS, Carman CV, et al: Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression. Nature 424: 561-565, 2003. (Pubitemid 36975778)
7. Radyuk SN, Michalak K, Klichko VI, Benes J and Orr WC: Peroxiredoxin 5 modulates immune response in Drosophila. Biochim Biophys Acta 1800: 1153-1163, 2010.
8. Lee TH, Kim SU, Yu SL, et al: Peroxiredoxin II is essential for sustaining life span of erythrocytes in mice. Blood 101: 5033-5038, 2003.
9. Yang CS, Lee DS, Song CH, et al: Roles of peroxiredoxin II in the regulation of proinflammatory responses to LPS and protection against endotoxin-induced lethal shock. J Exp Med 204: 583-594, 2007. (Pubitemid 46457081)
10. Kumin A, Huber C, Rulicke T, Wolf E and Werner S: Peroxiredoxin 6 is a potent cytoprotective enzyme in the epidermis. Am J Pathol 169: 1194-1205, 2006. (Pubitemid 351194356)
11. Kropotov A, Sedova V, Ivanov V, et al: A novel human DNA- binding protein with sequence similarity to a subfamily of redox proteins which is able to repress RNA-polymerase-III-driven transcription of the Alu-family retroposons in vitro. Eur J Biochem 260: 336-346, 1999. (Pubitemid 29122528)
12. Knoops B, Clippe A, Bogard C, et al: Cloning and characterization of AOEB166, a novel mammalian antioxidant enzyme of the peroxiredoxin family. J Biol Chem 274: 30451-30458, 1999.
13. Declercq JP and Evrard C: A twinned monoclinic crystal form of human peroxiredoxin 5 with eight molecules in the asymmetric unit. Acta Crystallogr D Biol Crystallogr 57: 1829-1835, 2001.
14. Nguyen-Nhu NT, Berck J, Clippe A, et al: Human peroxiredoxin 5 gene organization, initial characterization of its promoter and identification of alternative forms of mRNA. Biochim Biophys Acta 1769: 472-483, 2007. (Pubitemid 47081206)
15. Shiota M, Izumi H, Miyamoto N, et al: Ets regulates peroxi-redoxin1 and 5 expressions through their interaction with the high-mobility group protein B1. Cancer Sci 99: 1950-1959, 2008.
16. Kropotov AV, Grudinkin PS, Pleskach NM, Gavrilov BA, Tomilin NV and Zhivotovsky B: Downregulation of peroxiredoxin V stimulates formation of etoposide-induced double-strand DNA breaks. FEBS Lett 572: 75-79, 2004. (Pubitemid 39092516)
17. Banmeyer I, Marchand C, Clippe A and Knoops B: Human mitochondrial peroxiredoxin 5 protects from mitochondrial DNA damages induced by hydrogen peroxide. FEBS Lett 579: 2327-2333, 2005. (Pubitemid 40569500)
18. Kropotov A, Gogvadze V, Shupliakov O, et al: Peroxiredoxin V is essential for protection against apoptosis in human lung carcinoma cells. Exp Cell Res 312: 2806-2815, 2006.
19. Radyuk SN, Michalak K, Klichko VI, et al: Peroxiredoxin 5 confers protection against oxidative stress and apoptosis and also promotes longevity in Drosophila. Biochem J 419: 437-445, 2009.
20. Karihtala P, Mantyniemi A, Kang SW, Kinnula VL and Soini Y: Peroxiredoxins in breast carcinoma. Clin Cancer Res 9: 3418-3424, 2003. (Pubitemid 37082738)
21. Takabatake D, Fujita T, Shien T, et al: Tumor inhibitory effect of gefitinib (ZD1839, Iressa) and taxane combination therapy in EGFR-overexpressing breast cancer cell lines (MCF7/ADR, MDA-MB-231). Int J Cancer 120: 181-188, 2007. (Pubitemid 44901934)
22. Brunner N, Frandsen TL, Holst-Hansen C, et al: MCF7/LCC2: a 4-hydroxytamoxifen resistant human breast cancer variant that retains sensitivity to the steroidal antiestrogen ICI 182,780. Cancer Res 53: 3229-3232, 1993. (Pubitemid 23223286)
23. Mehta K: High levels of transglutaminase expression in doxorubicin- resistant human breast carcinoma cells. Int J Cancer 58: 400-406, 1994.
24. Murphy MP: How mitochondria produce reactive oxygen species. Biochem J 417: 1-13, 2009.
25. Fridovich I: Fundamental aspects of reactive oxygen species, or what's the matter with oxygen? Ann N Y Acad Sci 893: 13-18, 1999.
26. Kamata H and Hirata H: Redox regulation of cellular signalling. Cell Signal 11: 1-14, 1999. (Pubitemid 28546635)
27. Sauer H, Wartenberg M and Hescheler J: Reactive oxygen species as intracellular messengers during cell growth and differentiation. Cell Physiol Biochem 11: 173-186, 2001. (Pubitemid 32786086)
28. Circu ML and Aw TY: Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic Biol Med 48: 749-762, 2010.
29. Morise Z, Ueda M, Kitajima M, Epstein CJ, Granger DN and Grisham MB: Reactive oxygen species and vascular cell adhesion molecule-1 in distant organ failure following bile duct obstruction in mice. Dig Dis Sci 47: 607-613, 2002. (Pubitemid 34218892)
30. Avery SV: Molecular targets of oxidative stress. Biochem J 434: 201-210, 2011.
31. Bartosz G: Reactive oxygen species: destroyers or messengers? Biochem Pharmacol 77: 1303-1315, 2009.
32. Maccarrone M and Ullrich V: Redox regulation in disease and ageing. Cell Death Differ 11: 949-951, 2004. (Pubitemid 39139756)
33. Clerkin JS, Naughton R, Quiney C and Cotter TG: Mechanisms of ROS modulated cell survival during carcinogenesis. Cancer Lett 266: 30-36, 2008.
34. Kim YJ, Ahn JY, Liang P, Ip C, Zhang Y and Park YM: Human Prx1 gene is a target of Nrf2 and is up-regulated by hypoxia/reoxygenation: implication to tumor biology. Cancer Res 67: 546-554, 2007. (Pubitemid 46192191)
35. Graves JA, Metukuri M, Scott D, Rothermund K and Prochownik EV: Regulation of reactive oxygen species homeostasis by peroxiredoxins and c-Myc. J Biol Chem 284: 6520-6529, 2009.
36. Mikhailov VM, Kropotov AV, Zelenin AV, et al: [The BCL-xL and ACR-1 genes promote differentiation and reduce apoptosis in muscle fibers of mdx mice]. Genetika 38: 1445-1450, 2002.
37. Yuan J, Murrell GA, Trickett A, Landtmeters M, Knoops B and Wang MX: Overexpression of antioxidant enzyme peroxiredoxin 5 protects human tendon cells against apoptosis and loss of cellular function during oxidative stress. Biochim Biophys Acta 1693: 37-45, 2004. (Pubitemid 38970134)
38. Banmeyer I, Marchand C, Verhaeghe C, Vucic B, Rees JF and Knoops B: Overexpression of human peroxiredoxin 5 in subcellular compartments of Chinese hamster ovary cells: effects on cytotoxicity and DNA damage caused by peroxides. Free Radic Biol Med 36: 65-77, 2004. (Pubitemid 38068292)
39. Aprelikova O, Wood M, Tackett S, Chandramouli GV and Barrett JC: Role of ETS transcription factors in the hypoxia-inducible factor-2 target gene selection. Cancer Res 66: 5641-5647, 2006. (Pubitemid 43927116)
40. Bocchinfuso WP and Korach KS: Mammary gland development and tumorigenesis in estrogen receptor knockout mice. J Mal Gland Biol Neoplasia 2: 323-334, 1997.
41. Blobel GA and Orkin SH: Estrogen-induced apoptosis by inhibition of the erythroid transcription factor GATA-1. Mol Cell Biol 16: 1687-1694, 1996. (Pubitemid 26095641)
42. Blobel GA, Sieff CA and Orkin SH: Ligand-dependent repression of the erythroid transcription factor GATA-1 by the estrogen receptor. Mol Cell Biol 15: 3147-3153, 1995.
43. Chang M, Peng KW, Kastrati I, et al: Activation of estrogen receptor-mediated gene transcription by the equine estrogen metabolite, 4-methoxyequilenin, in human breast cancer cells. Endocrinology 148: 4793-4802, 2007. (Pubitemid 47481516)
44. Tsai SF, Martin DI, Zon LI, D'Andrea AD, Wong GG and Orkin SH: Cloning of cDNA for the major DNA-binding protein of the erythroid lineage through expression in mammalian cells. Nature 339: 446-451, 1989. (Pubitemid 19145788)
45. Evans T, Reitman M and Felsenfeld G: An erythrocyte-specific DNA-binding factor recognizes a regulatory sequence common to all chicken globin genes. Proc Natl Acad Sci USA 85: 5976-5980, 1988.
46. Newton A, Mackay J and Crossley M: The N-terminal zinc finger of the erythroid transcription factor GATA-1 binds GATC motifs in DNA. J Biol Chem 276: 35794-35801, 2001.
47. Tsang AP, Visvader JE, Turner CA, et al: FOG, a multitype zinc finger protein, acts as a cofactor for transcription factor GATA-1 in erythroid and megakaryocytic differentiation. Cell 90: 109-119, 1997. (Pubitemid 28009423)
48. Normanno N, Di Maio M, De Maio E, et al: Mechanisms of endocrine resistance and novel therapeutic strategies in breast cancer. Endocr Relat Cancer 12: 721-747, 2005. (Pubitemid 41815773)
49. Wang LH, Yang XY, Zhang X, et al: Disruption of estrogen receptor DNA-binding domain and related intramolecular communication restores tamoxifen sensitivity in resistant breast cancer. Cancer Cell 10: 487-499, 2006. (Pubitemid 44872981)